TBPH
Theravance Biopharma, Inc.
-0.01 (-0.03%)17.03USD102K成交股數884M市值7.0本益比(近四季)7.9股價營收比-20.9%營收年增(近四季)2026-11-10下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 20.7M-21% | 17.7M+15% | 45.9M+145% | 20.0M+19% | 26.2M+84% | 15.4M+6% | 18.8M+7% | 16.9M+7% | 14.3M | 14.5M | 17.6M | 15.7M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 4.7M | 5.8M | – | 8.1M | 10.5M | 11.5M | – | 9.3M | 10.0M | 9.0M | – | 8.3M |
| 銷售管理費用 | 14.2M | 17.7M | – | 18.3M | 18.4M | 18.4M | – | 16.9M | 17.1M | 16.7M | – | 16.1M |
| 營業利益 | −8.3M+204% | −9.5M-34% | 20.0M-318% | −6.5M-40% | −2.7M-83% | −14.4M+29% | −9.2M+47% | −10.8M+24% | −15.7M | −11.2M | −6.2M | −8.8M |
| 營業利益率 | -39.9% | -53.6% | 43.6% | -32.3% | -10.4% | -93.8% | -49.1% | -64.2% | -110.2% | -77.3% | -35.5% | -55.8% |
| 稅後淨利 | −5.9M-111% | −4.9M-64% | 61.0M-493% | 3.6M-128% | 54.8M-432% | −13.6M+16% | −15.5M+82% | −12.7M+42% | −16.5M | −11.7M | −8.5M | −9.0M |
| 淨利率 | -28.5% | -27.9% | 133.0% | 18.1% | 209.3% | -88.2% | -82.8% | -75.3% | -115.9% | -80.4% | -48.4% | -57.0% |
| 稀釋 EPS | -0.11-110% | -0.10-63% | 1.15-471% | 0.07-127% | 1.08-418% | -0.27+13% | -0.31+82% | -0.26+53% | -0.34 | -0.24 | -0.17 | -0.17 |
| 稀釋股數 | 51.7M | 51.3M | – | 51.9M | 50.7M | 49.7M | – | 49.0M | 48.7M | 48.3M | – | 52.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 220M | 288M | 168M | 175M | 282M | 111M | 37.8M | 23.4M | 46.3M | 53.8M | 39.5M | 71.7M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 470M | 472M | 486M | 415M | 426M | 344M | 354M | 356M | 362M | 371M | 382M | 414M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | 0.00 | – |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 290M | 291M | 297M | 233M | 225M | 166M | 176M | 186M | 194M | 205M | 213M | 246M |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | 39.5M | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 73.3M+70% | – | – | – | 43.0M-4311% | – | – | – | −1.0M | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | 91K | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | −1.1M | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | 445K | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | -7.7% | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 107M
| Single Reportable | 107M | 100.0% | +66.9% |
|---|
地區2025 年度 · 107M
| 美國 | 75.0M | 69.8% | +16.4% |
|---|---|---|---|
| 歐洲 | 32.5M | 30.2% | – |
產品／服務2025 年度 · 107M
| Collaborative Arrangement Revenue | 75.0M | 69.8% | +16.4% |
|---|---|---|---|
| Milestone | 25.0M | 23.3% | – |
| License | 7.5M | 7.0% | – |
| Licensing And Milestone 小計 | 32.5M | 30.2% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 107M | +66.9% | 106M | 98.5% | 2.06 | 238M |
| FY2024 | 64.4M | +12.1% | −56.4M | -87.6% | -1.15 | −11.9M |
| FY2023 | 57.4M | +11.8% | −55.2M | -96.1% | -1.00 | −29.5M |
| FY2022 | 51.3M | -7.2% | 872M | 1,698.5% | 11.85 | −188M |
| FY2021 | 55.3M | -23.0% | −199M | -360.6% | -2.87 | −211M |
| FY2020 | 71.9M | -2.1% | −278M | -386.9% | -4.46 | −257M |
| FY2019 | 73.4M | +21.6% | −236M | -322.1% | -4.25 | −241M |
| FY2018 | 60.4M | – | −216M | -357.0% | -3.99 | −120M |